Literature DB >> 33389104

Characterization of vB_VpaP_MGD2, a newly isolated bacteriophage with biocontrol potential against multidrug-resistant Vibrio parahaemolyticus.

Yanzi Cao1, Yujie Zhang1, Weiqing Lan1,2, Xiaohong Sun3,4.   

Abstract

Vibrio parahaemolyticus is a major foodborne pathogen and is also pathogenic to shrimp. Due to the emergence of multidrug-resistant V. parahaemolyticus strains, bacteriophages have shown promise as antimicrobial agents that could be used for controlling antibiotic-resistant strains. Here, a V. parahaemolyticus phage, vB_VpaP_MGD2, was isolated from a clam (Meretrix meretrix) and further characterized to evaluate its potential capability for biocontrol. Podophage vB_VpaP_MGD2 had a wide host range and was able to lyse 27 antibiotic-resistant V. parahaemolyticus strains. A one-step growth curve showed that vB_VpaP_MGD2 has a short latent period of 10 min and a large burst size of 244 phages per cell. Phage vB_VpaP_MGD2 was able to tolerate a wide range of temperature (30 °C-50 °C) and pH (pH 3-pH 10). Two multidrug-resistant strains (SH06 and SA411) were suppressed by treatment with phage vB_VpaP_MGD2 at a multiplicity of infection of 100 for 24 h without apparent regrowth of bacterial populations. The frequency of mutations causing bacteriophage resistance was relatively low (3.1 × 10-6). Phage vB_VpaP_MGD2 has a double-stranded DNA with a genome size of 45,105 bp. Among the 48 open reading frames annotated in the genome, no lysogenic genes or virulence genes were detected. Sequence comparisons suggested that vB_VpaP_MGD2 is a member of a new species in the genus Zindervirus within the subfamily Autographivirinae. This is the first report of a member of the genus Zindervirus that can infect V. parahaemolyticus. These findings suggest that vB_VpaP_MGD2 may be a candidate biocontrol agent against early mortality syndrome/acute hepatopancreatic necrosis disease (EMS/AHPND) caused by multidrug-resistant V. parahaemolyticus in shrimp production.

Entities:  

Year:  2021        PMID: 33389104     DOI: 10.1007/s00705-020-04887-x

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  36 in total

Review 1.  Chemicals and biological products used in south-east Asian shrimp farming, and their potential impact on the environment--a review.

Authors:  S Gräslund; B E Bengtsson
Journal:  Sci Total Environ       Date:  2001-12-03       Impact factor: 7.963

2.  Comparative genomic analysis unravels the transmission pattern and intra-species divergence of acute hepatopancreatic necrosis disease (AHPND)-causing Vibrio parahaemolyticus strains.

Authors:  Qian Yang; Xuan Dong; Guosi Xie; Songzhe Fu; Peizhuo Zou; Jing Sun; Yi Wang; Jie Huang
Journal:  Mol Genet Genomics       Date:  2019-04-09       Impact factor: 3.291

3.  Occurrence of pathogenic Vibrio parahaemolyticus in seafood distribution channels and their antibiotic resistance profiles in S. Korea.

Authors:  Y Lee; Y Choi; S Lee; H Lee; S Kim; J Ha; J Lee; H Oh; Y Kim; Y Yoon
Journal:  Lett Appl Microbiol       Date:  2019-01-04       Impact factor: 2.858

Review 4.  Progress, challenges and opportunities in fish vaccine development.

Authors:  Alexandra Adams
Journal:  Fish Shellfish Immunol       Date:  2019-04-27       Impact factor: 4.581

5.  Virulence and Antibiotic Resistance of Vibrio parahaemolyticus Isolates from Seafood from Three Developing Countries and of Worldwide Environmental, Seafood, and Clinical Isolates from 2000 to 2017.

Authors:  Mohammad M Obaidat; Alaa E Bani Salman; Amira A Roess
Journal:  J Food Prot       Date:  2017-12       Impact factor: 2.077

6.  Prevalence and antimicrobial susceptibility of Vibrio parahaemolyticus isolated from retail shrimps in Malaysia.

Authors:  Vengadesh Letchumanan; Wai-Fong Yin; Learn-Han Lee; Kok-Gan Chan
Journal:  Front Microbiol       Date:  2015-01-30       Impact factor: 5.640

Review 7.  A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens.

Authors:  Xavier Wittebole; Sophie De Roock; Steven M Opal
Journal:  Virulence       Date:  2013-08-13       Impact factor: 5.882

8.  Antimicrobial susceptibility of Vibrio vulnificus and Vibrio parahaemolyticus recovered from recreational and commercial areas of Chesapeake Bay and Maryland Coastal Bays.

Authors:  Kristi S Shaw; Rachel E Rosenberg Goldstein; Xin He; John M Jacobs; Byron C Crump; Amy R Sapkota
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

9.  Prevalence, characterization, and antibiotic susceptibility of Vibrio parahaemolyticus isolated from retail aquatic products in North China.

Authors:  Xiaoke Xu; Jianheng Cheng; Qingping Wu; Jumei Zhang; Tengfei Xie
Journal:  BMC Microbiol       Date:  2016-03-09       Impact factor: 3.605

10.  Characterization and CRISPR-based genotyping of clinical trh-positive Vibrio parahaemolyticus.

Authors:  Jetnapang Kongrueng; Kanchana Srinitiwarawong; Mitsuaki Nishibuchi; Pimonsri Mittraparp-Arthorn; Varaporn Vuddhakul
Journal:  Gut Pathog       Date:  2018-11-13       Impact factor: 4.181

View more
  3 in total

1.  Isolation and Characterization of a Lytic Vibrio parahaemolyticus Phage vB_VpaP_GHSM17 from Sewage Samples.

Authors:  Xunru Liang; Yuhang Wang; Bin Hong; Yanmei Li; Yi Ma; Jufang Wang
Journal:  Viruses       Date:  2022-07-22       Impact factor: 5.818

2.  Characterization and Genomic Analysis of Novel Vibrio parahaemolyticus Phage vB_VpaP_DE10.

Authors:  Yuanming Ye; Hanfang Chen; Qiaolan Huang; Shixuan Huang; Jiaxin He; Jumei Zhang; Qingping Wu; Xueling Li; Wenfeng Hu; Meiyan Yang
Journal:  Viruses       Date:  2022-07-23       Impact factor: 5.818

3.  Prophage-encoded gene VpaChn25_0734 amplifies ecological persistence of Vibrio parahaemolyticus CHN25.

Authors:  Yingwei Xu; Lianzhi Yang; Yaping Wang; Zhuoying Zhu; Jizhou Yan; Si Qin; Lanming Chen
Journal:  Curr Genet       Date:  2022-01-22       Impact factor: 3.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.